Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST.
Urbini M, Indio V, Tarantino G, Ravegnini G, Angelini S, Nannini M, Saponara M, Santini D, Ceccarelli C, Fiorentino M, Vincenzi B, Fumagalli E, Casali PG, Grignani G, Pession A, Ardizzoni A, Astolfi A, Pantaleo MA. Urbini M, et al. Among authors: fumagalli e. Genes Chromosomes Cancer. 2019 Sep;58(9):636-642. doi: 10.1002/gcc.22753. Epub 2019 Apr 16. Genes Chromosomes Cancer. 2019. PMID: 30887595 Free PMC article.
Imatinib mesylate in chordoma.
Casali PG, Messina A, Stacchiotti S, Tamborini E, Crippa F, Gronchi A, Orlandi R, Ripamonti C, Spreafico C, Bertieri R, Bertulli R, Colecchia M, Fumagalli E, Greco A, Grosso F, Olmi P, Pierotti MA, Pilotti S. Casali PG, et al. Among authors: fumagalli e. Cancer. 2004 Nov 1;101(9):2086-97. doi: 10.1002/cncr.20618. Cancer. 2004. PMID: 15372471 Free article.
Activate and resist: L576P-KIT in GIST.
Conca E, Negri T, Gronchi A, Fumagalli E, Tamborini E, Pavan GM, Fermeglia M, Pierotti MA, Pricl S, Pilotti S. Conca E, et al. Among authors: fumagalli e. Mol Cancer Ther. 2009 Sep;8(9):2491-5. doi: 10.1158/1535-7163.MCT-09-0662. Epub 2009 Sep 1. Mol Cancer Ther. 2009. PMID: 19723893
Adjuvant therapy of gastrointestinal stromal tumors (GIST).
Casali PG, Fumagalli E, Gronchi A. Casali PG, et al. Among authors: fumagalli e. Curr Treat Options Oncol. 2012 Sep;13(3):277-84. doi: 10.1007/s11864-012-0198-0. Curr Treat Options Oncol. 2012. PMID: 22743760 Review.
Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy.
Angelini S, Pantaleo MA, Ravegnini G, Zenesini C, Cavrini G, Nannini M, Fumagalli E, Palassini E, Saponara M, Di Battista M, Casali PG, Hrelia P, Cantelli-Forti G, Biasco G. Angelini S, et al. Among authors: fumagalli e. Pharmacol Res. 2013 Feb;68(1):1-6. doi: 10.1016/j.phrs.2012.10.015. Epub 2012 Nov 2. Pharmacol Res. 2013. PMID: 23127916
148 results